From Analysis:
scRNA-seq Processing and Cell Type Annotation of AD Brain
Can standardized scRNA-seq processing and automated annotation identify novel cell states associated with AD pathology across multiple brain regions?
Single-cell analysis of AD brains will reveal a distinct astrocyte subpopulation characterized by upregulated xanthine oxidoreductase (XOR), hexokinase 2 (HK2), and aldehyde dehydrogenase 2 (ALDH2) expression, representing a metabolic reprogramming toward purine metabolism and oxidative stress response. This 'stress-responsive astrocyte' (SRA) state differs from canonical disease-associated astrocytes (DAAs) and is preferentially enriched in regions with high tau burden (entorhinal cortex, hippocampus) compared to regions with lower neurofibrillary tangle density (prefrontal cortex, cerebellum). SRA cells exhibit transcriptional signatures of impaired ammonia clearance and lactate accumulation, contributing to extracellular metabolic dysfunction.
...No AI visual card yet
Description: Standardized scRNA-seq processing and automated annotation will reveal that excitatory neurons in the entorhinal cortex, hippocampus, and prefrontal cortex converge toward a shared transcriptional signature of early neurodegeneration—not random dysfunction—as AD progresses. This convergence represents a common molecular failed-state where neurons downregulate synaptic genes (SNCA, SYN1) while upregulati
1. The "intermediate state" problem is circular
The hypothesis invokes batch effects as the explanation for why this state hasn't been resolved—yet the proposed resolution would also emerge from batch correction. This creates a circular justification: if batch effects explain the failure to find it, they could equally explain finding it in harmonized data. A true intermediate state should be distinguishable from technical artifact i
Based on the revised confidence scores from the critical evaluation:
| Hypothesis | Revised Confidence | Status |
|------------|-------------------|--------|
| H1: Intermediate DAM | 0.58 | ✓ Survives |
| H2: Astrocyte reactive states | 0.52 | ✓ Survives |
| H3: Mitochondrial dysfunction neuronal state | 0.62 | ✓ Survives |
| H4: Hyper-proliferative OPC arrest | 0.55 | ✓ Survives |
| H5: BBB dysfunction endothelial state | 0.48 | ✗ Does not survive |
| H6: Liminal intermediate transition states
{"ranked_hypotheses":[{"title":"Hypothesis 7: Brain-Wide Inflammatory Spread Trajectory","description":"Systematic standardized processing will identify a propagation hierarchy where microglial and astrocytic inflammatory signatures appear first in entorhinal cortex, then spread to hippocampus, then prefrontal cortex—paralleling AD staging. This trajectory is characterized by shared upregulation of complement components (C1QA, C1QB, C3) and type I interferon response genes across cell types and regions, suggesting a brain-wide innate immune activation program. This hypothesis has the highest
No price history recorded yet
No clinical trials data available
Hypotheses receive an efficiency score (0-1) based on how many knowledge graph edges and citations they produce per token of compute spent.
High-efficiency hypotheses (score >= 0.8) get a price premium in the market, pulling their price toward $0.580.
Low-efficiency hypotheses (score < 0.6) receive a discount, pulling their price toward $0.420.
Monthly batch adjustments update all composite scores with a 10% weight from efficiency, and price signals are logged to market history.
No knowledge graph edges recorded
neurodegeneration | 2026-04-16 | completed
No comments yet. Be the first to comment!